noscript

News and Announcements

Proteomics International Receives R&D Tax Incentive

  • Published November 18, 2015 12:06PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

18th November 2015, ASX Announcement

Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL)  is pleased to announce it has received an Australian Government R&D Tax Incentive payment of $309,010 for the year ending 30 June 2015.

The Company received the R&D Tax Incentive after spending in excess of $700,000 on R&D activities within its world leading proteomics-focused business in the 2014-15 financial year.

The funds from the R&D Tax Incentive will complement PILL’s existing cash reserves and be used to continue to advance the application and commercialisation of the Company’s products and services derived from its proteomics-based technology platform.

Proteomics is the industrial scale study of the structure and function of proteins and PILL is recognised as a global leader in its field.

To read the full announcement, please click here

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now